These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21306295)

  • 1. Formulation study of topically applied O/W lotion containing vitamin D3 derivative, focusing on skin permeability of the drug.
    Harada S; Horisawa E; Kano S; Sugibayashi K
    Drug Dev Ind Pharm; 2011 Aug; 37(8):917-25. PubMed ID: 21306295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of in vitro skin permeation of 22-oxacalcitriol from ointments based on a two- or three-layer diffusion model considering diffusivity in a vehicle.
    Yamaguchi K; Mitsui T; Aso Y; Sugibayashi K
    Int J Pharm; 2007 May; 336(2):310-8. PubMed ID: 17240092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous pharmacokinetics of topically applied maxacalcitol ointment and lotion.
    Umemura K; Ikeda Y; Kondo K; Hirata K; Amagishi H; Ishihama Y; Tokura Y
    Int J Clin Pharmacol Ther; 2008 Jun; 46(6):289-94. PubMed ID: 18541125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
    Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microemulsions as topical delivery vehicles for the anti-melanoma prodrug, temozolomide hexyl ester (TMZA-HE).
    Suppasansatorn P; Nimmannit U; Conway BR; Du L; Wang Y
    J Pharm Pharmacol; 2007 Jun; 59(6):787-94. PubMed ID: 17637171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of in vitro skin permeation of 22-oxacalcitriol having a complicated metabolic pathway.
    Yamaguchi K; Mitsui T; Yamamoto T; Shiokawa R; Nomiyama Y; Ohishi N; Aso Y; Sugibayashi K
    Pharm Res; 2006 Apr; 23(4):680-8. PubMed ID: 16550468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study.
    Jayaraman SC; Ramachandran C; Weiner N
    J Pharm Sci; 1996 Oct; 85(10):1082-4. PubMed ID: 8897275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of creams and ointments as suitable formulations for peldesine.
    Viegas TX; Van Winkle LL; Lehman PA; Franz SF; Franz TJ
    Int J Pharm; 2001 May; 219(1-2):73-80. PubMed ID: 11337167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of carbenoxolone for delivery to the skin.
    Hirata K; Helal F; Hadgraft J; Lane ME
    Int J Pharm; 2013 May; 448(2):360-5. PubMed ID: 23545397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcipotriol delivery into the skin with PEGylated liposomes.
    Knudsen NØ; Rønholt S; Salte RD; Jorgensen L; Thormann T; Basse LH; Hansen J; Frokjaer S; Foged C
    Eur J Pharm Biopharm; 2012 Aug; 81(3):532-9. PubMed ID: 22538098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical delivery of anthramycin II. Influence of binary and ternary solvent systems.
    Haque T; Rahman KM; Thurston DE; Hadgraft J; Lane ME
    Eur J Pharm Sci; 2018 Aug; 121():59-64. PubMed ID: 29746912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
    Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
    Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
    Panchagnula R; Desu H; Jain A; Khandavilli S
    Farmaco; 2005; 60(11-12):894-9. PubMed ID: 16126203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced skin permeation of a new capsaicin derivative (DA-5018) from a binary vehicle system composed of isopropyl myristate and ethoxydiglycol.
    Cha BJ; Lee ED; Kim WB; Chung SJ; Lee MH; Shim CK
    Arch Pharm Res; 2001 Jun; 24(3):224-8. PubMed ID: 11440082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing vehicle effects on skin absorption using artificial membrane assays.
    Karadzovska D; Riviere JE
    Eur J Pharm Sci; 2013 Dec; 50(5):569-76. PubMed ID: 23474357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation effects of topical emulsions on transdermal and dermal delivery.
    Otto A; du Plessis J; Wiechers JW
    Int J Cosmet Sci; 2009 Feb; 31(1):1-19. PubMed ID: 19134123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation.
    Watkinson RM; Guy RH; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2009; 22(4):225-30. PubMed ID: 19648784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moisturizing lotions can increase transdermal absorption of the herbicide 2,4-dichlorophenoxacetic acid across hairless mouse skin.
    Brand RM; Charron AR; Sandler VL; Jendrzejewski JL
    Cutan Ocul Toxicol; 2007; 26(1):15-23. PubMed ID: 17464745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photostability and efficacy studies of topical formulations containing UV-filters combination and vitamins A, C and E.
    Gaspar LR; Campos PM
    Int J Pharm; 2007 Oct; 343(1-2):181-9. PubMed ID: 17614223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.